• Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

This page contains brief information about vemurafenib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA Approval for Vemurafenib for Erdheim-Chester Disease

FDA Approval for Vemurafenib for Melanoma

Use in Cancer

Vemurafenib is approved to treat patients whose disease has a certain mutation in the BRAF gene, including:

Vemurafenib is also being studied in the treatment of other types of cancer.

More About Vemurafenib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Vemurafenib - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

New Therapies Are Changing the Outlook for Advanced Melanoma

Targeted Cancer Therapies

New Therapies Offer Valuable Options for Patients with Melanoma

Clinical Trials Accepting Patients

Find Clinical Trials for Vemurafenib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: September 9, 2011
  • Updated: November 9, 2017